Literature DB >> 16139569

Evaluation of platelet parameters in healthy apheresis donors using the ADVIA 120.

Ahmet Ifran1, Adnan Haşimi, Kürşat Kaptan, Oral Nevruz, Cengiz Beyan, Kemal Erbil.   

Abstract

Platelet apheresis is accepted as a safe procedure and no clinically important change is observed after apheresis. The ADVIA 120 provides both an accurate platelet count and parameters describing platelet morphology and function. We studied the changes in platelet parameters of 35 healthy apheresis donors using the ADVIA 120. The mean platelet component value did not change after apheresis but the value of the platelet count was low and this reduction could be due to activation of platelets. We conclude that no remarkable changes were noted except the reduction in platelet numbers and plateletcrit which were expected to return to normal values in a few days.

Mesh:

Year:  2005        PMID: 16139569     DOI: 10.1016/j.transci.2005.04.007

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  6 in total

1.  Predictive and prognostic role of mean platelet volume in patients with first-ever acute ischemic stroke.

Authors:  Ugur Lok; Umut Gulacti; Burcu Ekmekci; Taner Bulut; Murat Celik
Journal:  Neurosciences (Riyadh)       Date:  2017-04       Impact factor: 0.906

2.  Prognostic evaluation of resectable colorectal cancer using platelet-associated indicators.

Authors:  Weihua Qian; Xin-Xin Ge; Jing Wu; Fei-Ran Gong; Meng-Yao Wu; Meng-Dan Xu; Lian Lian; Wen-Jie Wang; Wei Li; Min Tao
Journal:  Oncol Lett       Date:  2019-05-21       Impact factor: 2.967

3.  Prognostic Values of Platelet-Associated Indicators in Resectable Lung Cancers.

Authors:  Jing-Jing Wang; Yin-Ling Wang; Xin-Xin Ge; Meng-Dan Xu; Kai Chen; Meng-Yao Wu; Fei-Ran Gong; Min Tao; Wen-Jie Wang; Liu-Mei Shou; Wei Li
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

4.  Effect of plateletpheresis on hematocrit, hemoglobin and erythrocyte count: Meta-analysis 1980-2018.

Authors:  Alejandro Gil-Betacur; Carmen Yulieth Mantilla-Gutiérrez; Jaiberth Antonio Cardona-Arias
Journal:  Sci Rep       Date:  2019-12-24       Impact factor: 4.379

5.  Preoperative plateletcrit is a Prognostic Biomarker for Survival in Patients with Non-Small Cell Lung Cancer.

Authors:  Joon Young Hur; Ha Yeon Lee; Hye Jung Chang; Cheon Woong Choi; Dae Hyun Kim; Wan Kyu Eo
Journal:  J Cancer       Date:  2020-02-25       Impact factor: 4.207

6.  Prognostic values of platelet-associated indicators in advanced breast cancer.

Authors:  Yu-Jie Lu; Meng-Ting Cui; Zhan-Wen Liang; Wen-Jie Wang; Min Jiang; Meng-Dan Xu; Meng-Yao Wu; Meng Shen; Wei Li; Yuan Gao; Lian Lian; Wei-Ming Duan
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.